GL1X · GenesisL1 explorer

MolNFT v1 · #91047 · protein

Crystal structure of human PI3K-gamma in complex with a pyridyl- triazine-sulfonamide inhibitor

4F1S · Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic…: “Crystal structure of human PI3K-gamma in complex with a pyridyl- triazine-sulfonamide inhibitor”. X-ray diffraction, 2 ligands (F1S, SO4), 14 pockets (best druggability…

PDB
4F1S
Type
protein
Length
834 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
F1S, SO4
Pockets
14 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein83445% helix, 18% strandP48736

Ligands and binding sites

  • F1S · N-(5-{[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(tetrahydro-2H-pyran-4-yl)pyridin-2-yl]amino}-2-chloropyridin-3-yl)methanesulfonamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 6 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111630.830.8491SO4
21020.740.9635empty
33870.690.8144empty
43200.620.7831F1S
51440.590.8431empty

Compared structures

  • 4F1S · Crystal structure of human PI3K-gamma in complex with a pyridyl-triazine-sulfonamide… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.